Melanotan II vs PT-141

Melanotan II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (alpha-MSH). It acts as a non-selective agonist at all five melanocortin receptors (MC1R through MC5R), with documented effects on melanogenesis, appetite regulation, and behavioral pathways in preclinical models. Its broad receptor profile makes it a useful tool for studying melanocortin biology generally. PT-141 (also called bremelanotide) is a synthetic peptide derived from melanotan II through structural modification that produces MC3R and MC4R selectivity. By targeting only the central nervous system melanocortin receptors and excluding MC1R-mediated melanogenesis, PT-141 has been studied specifically for behavioral and CNS-mediated effects. It is the more refined research tool when isolating central melanocortin signaling.

Melanotan II

Receptor Selectivity Non-selective (MC1R-MC5R)
Origin Synthetic alpha-MSH analog
Melanogenesis Yes (MC1R activation)
Research Focus Broad melanocortin biology
Format Lyophilized peptide
Key Pathways cAMP, all MC receptor subtypes

PT-141

Receptor Selectivity MC3R/MC4R-selective
Origin Modified derivative of MT-II
Melanogenesis Minimal
Research Focus CNS-mediated behavioral effects
Format Pre-measured research kit
Key Pathways cAMP, central MC3R/MC4R signaling

The Verdict

Melanotan II and PT-141 are mechanistically related but serve different research purposes. MT-II offers a broad view of melanocortin biology by engaging all receptor subtypes, making it valuable when researchers want to observe combined effects across the system. PT-141 is the precise tool when isolating central MC3R/MC4R signaling without MC1R-mediated melanogenesis. The choice depends on whether the research question requires breadth or specificity.

Explore These Products

Melanotan II

A synthetic analog of alpha-melanocyte stimulating hormone (α-MSH) studied for its activation of melanocortin receptors (MC1R, MC3R, MC4R, MC5R) in pigmentation, metabolic, and behavioral research.

View Details →

PT-141

A PT-141 packaged as a plastic box containing 10 lyophilized 10mg vials.

View Details →

Melanotan II vs PT-141 — FAQ

How is PT-141 different from Melanotan II?
PT-141 is a structurally modified derivative of MT-II that produces selectivity for MC3R and MC4R receptors. This eliminates MC1R-mediated melanogenesis and most peripheral effects, focusing the compound on central nervous system pathways.
Why study melanocortin receptors?
Melanocortin receptors are involved in pigmentation (MC1R), adrenal function (MC2R), energy balance (MC3R/MC4R), and immune modulation (MC5R). They are studied across endocrinology, behavior, and metabolic research.
Can they be used together?
They are typically studied independently to isolate selective vs broad receptor effects. Comparative protocols are common to identify which outcomes depend on MC1R or MC5R engagement.
What is the regulatory status?
Both are sold as research-use-only compounds for in-vitro and preclinical study models.

References

Primary sources for key clinical and regulatory claims on this page.

  1. Synthesis of melanotropic peptides — Melanotan II — PubMed / Bioorg Med Chem . Foundational synthesis and characterization of MT-II as a non-selective melanocortin agonist.
  2. Bremelanotide (PT-141) — selective melanocortin receptor agonist — PubMed / Eur J Pharmacol . Primary reference for PT-141 receptor selectivity and CNS-mediated mechanism.

Keep Researching

Use the surrounding category and guide pages to move from a side-by-side comparison into the broader decision path.

Research Peptides CategoryResearch Kits Category
Updated March 2026. This comparison is reviewed for catalog accuracy, sourcing language, and consistency with our public quality standards. It is an educational summary for research reference only. Read our Editorial Standards.

Ready to order?

Pick your product and check out in under 3 minutes.

Shop Now